Huntsman Cancer Institute at the University of Utah (the U) faculty and staff continue to set new standards in cancer research, clinical innovation, and community engagement. The faculty and staff’s ...

"3T is tackling one of the toughest challenges in immuno-oncology: delivering potent, selective TCR therapies for solid tumors," said Dr. Knudsen. "The science is compelling, and the opportunity for ...

Nearly 15 percent of U.S. adults continue to smoke, often because long-term health risks feel too abstract compared with the ...

Marisa Abela, the star of HBO's Industry, just revealed major health news. The 29-year-old opened up about a cancer diagnosis ...

THE notion that beer can be good for you is by no means new. In the 1950s, the makers of Guinness claimed their brew was a ...

Hippocratic AI, the global leader and pioneer in patient-facing generative AI healthcare agents, today announced a major expansion of its life sciences business. The company has acquired Grove AI, ...

According to a 2025 survey conducted by the Prevent Cancer Foundation, only 51% of U.S. adults 21 and older say they have had ...

Introduction Integrating smoking cessation supports into lung cancer screening can improve abstinence rates. However, ...

Mr. Lucido succeeded Kent Emry, who has served on BioCorRx’s Board of Directors since 2013 and will continue to serve as an independent director, ensuring continuity of leadership and governance.

Mr. Lucido succeeded Kent Emry, who has served on BioCorRx’s Board of Directors since 2013 and will continue to serve as an independent director, ensuring continuity of leadership and governance.

Last year, the Food and Drug Administration approved the first at-home test that can detect three common infections in women ...

As we look ahead to 2026, we need to continue to be proactive about our health care. With an upcoming second Trump administration, some in the Black community are fearful of what that can mean for ...